Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

546 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acromegaly management in the Nordic countries: A Delphi consensus survey.
Arlien-Søborg MC, Dal J, Heck A, Stochholm K, Husted E, Feltoft CL, Rasmussen ÅK, Feldt-Rasmussen U, Andreassen M, Klose MC, Nielsen TL, Andersen MS, Christensen LL, Krogh J, Jarlov A, Bollerslev J, Nermoen I, Oksnes M, Dahlqvist P, Olsson T, Berinder K, Hoybye C, Petersson M, Akerman AK, Wahlberg J, Ekman B, Engstrom BE, Johannsson G, Ragnarsson O, Olsson D, Sigurjónsdóttir HÁ, Fougner SL, Matikainen N, Vehkavaara S, Metso S, Jaatinen P, Hämäläinen P, Rintamäki R, Yliaska I, Immonen H, Mäkimattila S, Cederberg-Tamminen H, Viukari M, Nevalainen P, Nuutila P, Schalin-Jäntti C, Burman P, Jørgensen JOL. Arlien-Søborg MC, et al. Clin Endocrinol (Oxf). 2024 Sep;101(3):263-273. doi: 10.1111/cen.15095. Epub 2024 Jun 12. Clin Endocrinol (Oxf). 2024. PMID: 38865284
Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing's disease receiving pasireotide treatment: post hoc analyses from the SOM230B2219 study.
Feldt-Rasmussen U, Bolanowski M, Zhang SL, Yu Y, Witek P, Kalra P, Kietsiriroje N, Piacentini A, Pedroncelli AM, Samson SL. Feldt-Rasmussen U, et al. Front Endocrinol (Lausanne). 2024 Mar 21;15:1250822. doi: 10.3389/fendo.2024.1250822. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38577574 Free PMC article. Clinical Trial.
Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH.
Touraine P, D'Souza GA, Kourides I, Abs R, Barclay P, Xie R, Pico A, Torres-Vela E, Ekman B; GH Lipoatrophy Study Group. Touraine P, et al. Eur J Endocrinol. 2009 Oct;161(4):533-40. doi: 10.1530/EJE-09-0422. Epub 2009 Aug 4. Eur J Endocrinol. 2009. PMID: 19654233 Clinical Trial.
Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study.
Pivonello R, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Trovato A, Hughes G, Salgado LR, Lacroix A, Schopohl J, Biller BM; Pasireotide B2305 Study Group. Pivonello R, et al. Clin Endocrinol (Oxf). 2014 Sep;81(3):408-17. doi: 10.1111/cen.12431. Epub 2014 Mar 27. Clin Endocrinol (Oxf). 2014. PMID: 24533697 Clinical Trial.
A 12-month phase 3 study of pasireotide in Cushing's disease.
Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM; Pasireotide B2305 Study Group. Colao A, et al. N Engl J Med. 2012 Mar 8;366(10):914-24. doi: 10.1056/NEJMoa1105743. N Engl J Med. 2012. PMID: 22397653 Free article. Clinical Trial.
Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants.
Geller F, Wu X, Lammi V, Abner E, Valliere JT, Nastou K, Rasmussen M, Andersson NW, Quinn L; DBDS Genomic Consortium; Aagaard B, Banasik K, Bliddal S, Boding L, Brunak S, Brøns N, Bybjerg-Grauholm J, Christoffersen LAN, Didriksen M, Dinh KM, Erikstrup C, Feldt-Rasmussen U, Grønbæk K, Kaspersen KA, Mikkelsen C, Nielsen CH, Nielsen HS, Nielsen SD, Nissen J, Sequeros CB, Tommerup N, Ullum H; Estonian Biobank Research Team; FinnGen, Spiliopoulos L, Bager P, Hviid A, Sørensen E, Pedersen OB, Lane JM, Lassaunière R, Ollila HM, Ostrowski SR, Feenstra B. Geller F, et al. Among authors: feldt rasmussen u. medRxiv [Preprint]. 2024 Nov 22:2024.11.21.24317689. doi: 10.1101/2024.11.21.24317689. medRxiv. 2024. PMID: 39606378 Free PMC article. Preprint. No abstract available.
Susceptibility to and severity of SARS-CoV-2 infection according to prescription drug use-an observational study of 46,506 Danish healthcare workers.
Eiken A, Bliddal S, Villumsen M, Iversen KK, Bundgaard H, Hasselbach RB, Kristensen JH, Nielsen PB, Pries-Heje MM, Knudsen AD, Fogh K, Norsk JB, Andersen O, Fischer TK, Dessau RB, Ostrowski SR, Torp-Pedersen C, Ditlev SB, Gybel-Brask M, Sørensen E, Harritshøj LH, Folke F, Benfield T, Engsig FN, Poulsen HE, Ullum H, Feldt-Rasmussen U, Nielsen SD, Rungby J. Eiken A, et al. Among authors: feldt rasmussen u. PLoS One. 2024 Nov 27;19(11):e0311260. doi: 10.1371/journal.pone.0311260. eCollection 2024. PLoS One. 2024. PMID: 39602471 Free PMC article.
Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors.
Jotanovic J, Boldt HB, Burton M, Andersen MS, Bengtsson D, Bontell TO, Ekman B, Engström BE, Feldt-Rasmussen U, Heck A, Jakovcevic A, Jørgensen JOL, Kraljevic I, Kunicki J, Lindsay JR, Losa M, Loughrey PB, Maiter D, Maksymowicz M, Manojlovic-Gacic E, Pahnke J, Petersenn S, Petersson M, Popovic V, Ragnarsson O, Rasmussen ÅK, Reisz Z, Saeger W, Schalin-Jäntti C, Scheie D, Terreni MR, Tynninen O, Whitelaw B, Burman P, Casar-Borota O. Jotanovic J, et al. Among authors: feldt rasmussen u. Acta Neuropathol. 2024 Nov 23;148(1):68. doi: 10.1007/s00401-024-02836-5. Acta Neuropathol. 2024. PMID: 39580368 Free PMC article.
Angiokeratomas in a patient with Fabry disease.
Al-Chaer RN, Mogensen M, Feldt-Rasmussen U, Nissen CV. Al-Chaer RN, et al. Among authors: feldt rasmussen u. Ugeskr Laeger. 2024 Oct 21;186(43):V03240232. doi: 10.61409/V03240232. Ugeskr Laeger. 2024. PMID: 39534937 Free article. Danish.
546 results